Image-guided adaptive radiotherapy in patients with locally advanced non-small cell lung cancer: the art of PET.
W. Grootjans, L. de Geus-Oei and J. BussinkArticles
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
2018
369--384
Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study.
M. Hekman, M. Rijpkema, C. Muselaers, E. Oosterwijk, C. de Hulsbergen-Van Kaa, O. Boerman, W. Oyen, J. Langenhuijsen and P. MuldersArticles
Theranostics
2018
2161--2170
Positron Emission Tomography/Computed Tomography with , javax.xml.bind.JAXBElement@51511e9, Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion.
M. Hekman, M. Rijpkema, E. Aarntzen, S. Mulder, J. Langenhuijsen, E. Oosterwijk, O. Boerman, W. Oyen and P. MuldersArticles
European urology
2018
257--260
Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging.
L. Joosten, M. Brom, H. Peeters, S. Heskamp, M. Béhé, O. Boerman and M. GotthardtArticles
Molecular pharmaceutics
2018
486--494
Digitalis-like compounds facilitate non-medullary thyroid cancer redifferentiation through intracellular Ca2+, FOS and autophagy dependent pathways.
M. Tesselaar, T. Crezee, H. Swarts, D. Gerrits, O. Boerman, J. Koenderink, H. Stunnenberg, M. Netea, J. Smit, R. Netea-Maier and T. PlantingaArticles
Molecular cancer therapeutics
2017
169-181
Clinical application of FDG-PET/CT in metastatic infections.
I. Kouijzer, F. Vos, C. Bleeker-Rovers and W. OyenArticles
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
2017
232--246
The Predictive Value of Early In-Treatment (18)F-FDG PET/CT Response to Chemotherapy in Combination with Bevacizumab in Advanced Nonsquamous Non-Small Cell Lung Cancer.
E. Usmanij, T. Natroshvili, J. Timmer-Bonte, W. Oyen, M. van der Drift, J. Bussink and L. Geus-OeiArticles
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
2017
1243--1248
Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin.
I. van der Kroon, W. der Woliner-van Weg, M. Brom, L. Joosten, C. Frielink, M. Konijnenberg, E. Visser and M. GotthardtArticles
Scientific reports
2017
39800
Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT
S. Lütje, B. Gomez, J. Cohnen, L. Umutlu, M. Gotthardt, T. Poeppel, A. Bockisch and S. Rosenbaum-KrummeArticles
Clinical nuclear medicine
2017
20--25
In Vivo Imaging of Antileukemic Drug Asparaginase Reveals a Rapid Macrophage-Mediated Clearance from the Bone Marrow.
L. van der Meer, S. Terry, D. van Ingen Schenau, K. Andree, G. Franssen, D. Roeleveld, J. Metselaar, T. Reinheckel, P. Hoogerbrugge, O. Boerman and F. van LeeuwenArticles
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
2017
214--220
Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic (18)F Fluorodeoxyglucose PET.
T. Meijer, L. de Geus-Oei, E. Visser, W. Oyen, M. Looijen-Salamon, D. Visvikis, A. Verhagen, J. Bussink and D. VriensArticles
Radiology
2017
547--559
Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging.
B. Frigerio, G. Franssen, E. Luison, A. Satta, E. Seregni, M. Colombatti, G. Fracasso, R. Valdagni, D. Mezzanzanica, O. Boerman, S. Canevari and M. FiginiArticles
Oncotarget
2017
10919--10930
Noninvasive Therapy Monitoring in Experimental Rheumatoid Arthritis
T. van der Geest2017
Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.
T. van der Geest, P. Laverman, D. Gerrits, B. Walgreen, M. Helsen, C. Klein, T. Nayak, G. Storm, J. Metselaar, M. Koenders and O. BoermanArticles
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
2017
151--155
Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer.
R. Nadar, N. Margiotta, M. Iafisco, J. van den Beucken, O. Boerman and S. LeeuwenburghArticles
Advanced healthcare materials
2017
Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT.
R. Wijsman, F. Dankers, E. Troost, A. Hoffmann, E. van der Heijden, L. de Geus-Oei and J. BussinkArticles
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
2017
295--299